Schubert, Carsten (Phoenixville, PA, US)
Grasberger, Bruce L. (Trappe, PA, US)
Schalk-hihi, Celine (Phoenixville, PA, US)
Maguire, Diane M. (Downingtown, PA, US)
Lewandowski, Frank A. (Washington Crossing, PA, US)
Milligan, Cynthia M. (Rutledge, PA, US)
Alexander, Richard S. (Newark, DE, US)
Janssen Pharmaceutica N.V. (Beerse, BE)
подача заявки 24.04.2009
публикация патента 20.12.2011
A number of soluble engineered forms of MGLL that are suitable for high-throughput screening and protein crystallization, as well as a crystallized form of monoacylglycerol lipase protein (MGLL) and descriptions of the X-ray diffraction patterns are disclosed. The engineered constructs of MGLL permit the expression and purification of protein suitable for crystallography or high-throughput screening and identification of ligands, which can function as active agents to MGLL. The X-ray diffraction patterns allow the three dimensional structure of MGLL to be determined at atomic resolution so that ligand binding sites on MGLL can be identified and the interactions of ligands with MGLL amino acid residues can be modeled. Models prepared using such maps permit the design of ligands which can function as active agents which include, but are not limited to, those that function as inhibitors of MGLL.
ФОРМУЛА ИЗОБРЕТЕНИЯ (CLAIMS)
What is claimed is:
1. The A crystal comprising monoacylglycerol lipase (MGLL) peptide consisting of SEQ ID NO: 7 and a ligand, wherein said ligand is selected from the group consisting of the following structures: and wherein said crystal has a space group of C2221; and a unit cell having dimensions of a=93.95 â„«, b=128.45 â„«, c=60.6 â„«.
2. A method for the production of a crystal complex comprising a monoacylglycerol lipase (MGLL) peptide consisting of SEQ ID NO: 7 with a ligand of the following structure: comprising: a. contacting the MGLL polypeptide with said ligand in a suitable solution comprising 8% PEG MME 5K, 100 mM Na Citrate pH5.5 and 2% n-Octyl-Beta-D-Glucopyranoside, and, b. crystallizing said resulting complex of MGLL polypeptide-ligand from said solution.